Mackenzie Financial Corp Bionano Genomics, Inc. Transaction History

Mackenzie Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	SELL	$0.36 - $36.0 $487 - $48,744	-1,354 Reduced 6.52%	19,406 $36,000
Q2 2022 Aug 10, 2022	BUY	$12.3 - $27.3 $49,655 - $110,210	4,037 Added 24.14%	20,760 $29,000
Q1 2022 May 13, 2022	BUY	$16.6 - $32.3 $20,849 - $40,568	1,256 Added 8.12%	16,723 $43,000
Q4 2021 Feb 14, 2022	SELL	$29.9 - $61.2 $31,813 - $65,116	-1,064 Reduced 6.44%	15,467 $46,000
Q3 2021 Nov 08, 2021	BUY	$51.4 - $68.2 $849,693 - $1.13 Million	16,531 New	16,531 $91,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $81.2M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.